How 3 dental technology companies performed in Q3

Here is how Align Technology, Biolase and Sonendo performed during the third quarter of 2023: 

Advertisement

Align Technology

  • Total revenue was $960.2 million.
  • Operating income was $166.3 million.
  • The company had more than $1.3 billion in cash, cash equivalents and short-term and long-term marketable securities as of Sept. 30.

Biolase

  • Total revenue was $10.9 million.
  • Total consumable sales were $2.9 million.
  • Total operating expenses were $7.4 million.
  • The company had cash and cash equivalents of approximately $7.8 million.

Sonendo

  • Total revenue was $10.4 million.
  • Total operating expenses were $18.5 million.
  • Net loss was $17 million.
  • The company had $55.9 million in cash and cash equivalents and short-term investments.

At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.

Advertisement

Next Up in Dental Technology

Advertisement

Comments are closed.